Patents : |  |
| US Patent No. | Title |
| 7605266 | Azaindole inhibitors of Aurora kinases
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7609061 | Demagnetized implant for magnetic resonance imaging
|
| 7611692 | Gastrin releasing peptide compounds
|
| 7611704 | Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7611854 | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
| 7611865 | Polynucleotides encoding truncated glial cell line-derived neurotrophic factor
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7611893 | Metal-binding therapeutic peptides
|
| 7612039 | Method of cell growth inhibition with agnoprotein
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608634 | Substituted pyrrolines as kinase inhibitors
|
| 7608255 | Replication-competent anti-cancer vectors
|
| 7608257 | Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
|
| 7608259 | Methods of cancer diagnosis and therapy targeted against a cancer stem line
|
| 7608260 | Stabilized immunoglobulins
|
| 7608264 | Antibodies that bind to pleiotrophin growth factor receptor
|
| 7608267 | Multifunctional cytokines
|
| 7608269 | Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7608429 | Methods and compositions for increasing antibody production
|
| 7608612 | Radiosensitizer formulations and methods for use
|
| 7612092 | Nitrogen-containing aromatic derivatives
|
| 7612162 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
| 7618631 | Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
|
| 7618633 | Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
|
| 7618637 | Heat shock protein-based vaccines and immunotherapies
|
| 7618816 | Metal-binding therapeutic peptides
|
| 7618936 | Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
|
| 7618939 | Compositions and methods to prevent cancer with cupredoxins
|
| 7618947 | Modulation of HIF-1 beta expression
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
| 7618626 | Combination treatment for non-hematologic malignancies
|
| 7618622 | Treatment of Parkinson's disease and related disorders using postpartum derived cells
|
| 7615632 | Crystalline forms of temozolomide
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612182 | Anti-IL-6 antibodies, compositions, methods and uses
|
| 7612202 | Process for preparing temozolomide
|
| 7615209 | Compositions of NDV and methods of use thereof for treatment of cancer
|
| 7615213 | Antibodies against human interleukin-13 and pharmaceutical compositions thereof
|
| 7615214 | Anti-human VEGF receptor Flt-1 monoclonal antibody
|
| 7615215 | Anti-human VEGF receptor Flt-1 monoclonal antibody
|
| 7615223 | Selected immunoconjugates for binding to aminophospholipids
|
| 7615353 | Tivozanib response prediction
|
| 7615529 | Methods and compositions for modulating hyperstabilized c-met
|
| 7619068 | Ovr110 antibody compositions and methods of use
|
